Roche Holding said its Tecentriq drug combined with platinum-based chemotherapy reduced the risk of the disease worsening or death in patients with advanced bladder cancer, the Swiss pharma company said on Monday.
from Reuters: Health News https://ift.tt/2YDFVGh
via
IFTTT
0 comments:
Post a Comment